Matheus Hideki Taborda

Dr. Matheus Hideki Taborda

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Medical Mycology Case Reports
Verified
Journal Article
Open access
RCRegielly Caroline Raimundo Cognialli
Regielly Caroline Raimundo Cognialli
MTMatheus Hideki Taborda
Matheus Hideki Taborda
BCBruno Hassunuma Carneiro
Bruno Hassunuma Carneiro
CPCarolina Melchior Do Prado
Carolina Melchior Do Prado
MWMariana Marques Wolski
Mariana Marques Wolski
FQFlávio de Queiroz-Telles
Flávio de Queiroz-Telles
Sporotrichosis is a growing public health concern especially due Sporothrix brasiliensis. We report a case of disseminated sporotrichosis involving the meninges, lungs, and testicles in a 35-year-old homeless man from Curitiba, Brazil. Fungal culture, histopathology, and molecular identification confirmed S. brasiliensis infection. Notably, testicular involvement—a rare complication of sporotrichosis—was initially misdiagnosed as a malignant tumor, leading to orchiectomy. A literature review identified only four previous cases of testicular sporotrichosis. This case underscores the potential for atypical presentations in immunocompromised patients and highlights the need for clinical vigilance in endemic regions, given the rising incidence of sporotrichosis.

10 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
MTMatheus Hideki Taborda
Matheus Hideki Taborda
JKJoão Rudolfo Kleinübing
João Rudolfo Kleinübing
DLDiego Ricardo Lodi Lauriano
Diego Ricardo Lodi Lauriano
JSJoão Victor de Oliveira Souza
João Victor de Oliveira Souza
LKLeonardo Kami
Leonardo Kami
BTBernardo Correa de Almeida Teixeira
Bernardo Correa de Almeida Teixeira
Central nervous system (CNS) lymphoproliferative disorders comprise a heterogeneous group of rare entities that present major diagnostic and therapeutic challenges. Primary CNS large B-cell lymphoma (LBCL) is the most common form and the second most frequent primary CNS tumor after gliomas. The 5th edition of the World Health Organization Classification of Hematolymphoid Tumours introduced updated terminology, including primary LBCL of immune-privileged sites and lymphomas arising in immunodeficiency/dysregulation, along with less common variants such as intravascular large B-cell lymphoma, lymphomatoid granulomatosis, lymphomatosis cerebri, secondary CNS lymphoma, mucosa-associated lymphoid tissue (MALT) lymphoma of the dura, and T-cell/NK-cell lymphomas. Immune status, Epstein–Barr virus association, and imaging features may assist differentiation, although biopsy remains essential for definitive diagnosis. On MRI, lesions are typically periventricular or involve the basal ganglia, showing low T2 signal intensity, restricted diffusion, and intense enhancement. Spectroscopy demonstrates elevated choline/N-acetylaspartate ratios with lipids, and perfusion is generally lower than in other neoplasms. Corticosteroid administration before biopsy should be avoided due to potential cytolysis of tumor cells. Major differential diagnoses include glioblastoma, metastases, demyelinating lesions, and infections such as toxoplasmosis, fungal abscess, and tuberculosis. Treatment may cause neurotoxicity and immunosuppression, predisposing patients to opportunistic infections.

1 May 2025 in Radiology: Imaging Cancer
Verified
Journal Article
Closed access
MTMatheus Hideki Taborda
Matheus Hideki Taborda
NBNathalia Luiza Ferri Bonmann
Nathalia Luiza Ferri Bonmann
DEDante Luiz Escuissato
Dante Luiz Escuissato

1 April 2026 in Radiology
Verified
Journal Article
Closed access
MTMatheus Hideki Taborda
Matheus Hideki Taborda
MPMatheus Kahakura Franco Pedro
Matheus Kahakura Franco Pedro
BTBernardo Correa de Almeida Teixeira
Bernardo Correa de Almeida Teixeira
History A 76-year-old man presented to the emergency department with a 1-month history of worsening binocular diplopia on left horizontal gaze, along with 1 week of progressive dysarthria and dizziness. Additionally, he had a chronic history of right-sided cervicobrachialgia related to degenerative disk disease, which had been improving with oral analgesia. The patient’s past medical history included hypertension, dyslipidemia, insomnia, and hypothyroidism. He also had postpolio syndrome affecting the right lower limb. He reported no fever, chills, cough, shortness of breath, abdominal pain, or chest pain. There was no history of rash, intravenous drug use, immunosuppressive medication use, or documented congenital abnormalities. He reported no recent or recurrent bacterial or viral infections. At clinical examination, the patient appeared tired and had a decreased level of alertness. He was hypertensive (165/91 mm Hg) but had a normal body temperature. Other vital signs were unremarkable. Neurologic assessment revealed left abducens nerve palsy, right lower facial palsy, horizontal nystagmus during right eye adduction, and right lower limb paresis with ipsilateral patellar hyperreflexia. Brain MRI performed the day after admission showed imaging abnormalities ( Figs 1 – 3 ). Laboratory testing showed an elevated C-reactive protein level (135 mg/L; upper limit of normal, 1 mg/L); other blood tests were within normal limits. Extensive additional diagnostic workup—including serologic testing for anti-aquaporin-4 antibody, anti-DNA antibody, lupus anticoagulant, antinuclear antibody, anti-cardiolipin antibody, and rheumatoid factor—yielded negative results. Lumbar puncture revealed a normal cerebrospinal fluid opening pressure (18 cm H 2 O; upper limit of normal, 25 cm H 2 O). The cerebrospinal fluid was clear, with a normal total nucleated cell count (3.75/mm 3 ; reference range, 0–5/mm 3 ), normal glucose level (53 mg/dL [2.9 mmol/L]; reference range, 50–77 mg/dL [2.8–4.3 mmol/L]), and elevated total protein level (750 mg/L; reference range, 100–450 mg/L). Cerebrospinal fluid oligoclonal bands were positive.

1 August 2026 in Radiology
Verified
Journal Article
Closed access
MTMatheus Hideki Taborda
Matheus Hideki Taborda
MPMatheus Kahakura Franco Pedro
Matheus Kahakura Franco Pedro
BTBernardo Correa de Almeida Teixeira
Bernardo Correa de Almeida Teixeira
History A 76-year-old man presented to the emergency department with a 1-month history of worsening binocular diplopia on left horizontal gaze, along with 1 week of progressive dysarthria and dizziness. Additionally, he had a chronic history of right-sided cervicobrachialgia related to degenerative disk disease, which had been improving with oral analgesia. The patient’s past medical history included hypertension, dyslipidemia, insomnia, and hypothyroidism. He also had postpolio syndrome affecting the right lower limb. He reported no fever, chills, cough, shortness of breath, abdominal pain, or chest pain. There was no history of rash, intravenous drug use, immunosuppressive medication use, or documented congenital abnormalities. He reported no recent or recurrent bacterial or viral infections. At clinical examination, the patient appeared tired and had a decreased level of alertness. He was hypertensive (165/91 mm Hg) but had a normal body temperature. Other vital signs were unremarkable. Neurologic assessment revealed left abducens nerve palsy, right lower facial palsy, horizontal nystagmus during right eye adduction, and right lower limb paresis with ipsilateral patellar hyperreflexia. Brain MRI performed the day after admission showed imaging abnormalities. Laboratory testing showed an elevated C-reactive protein level (135 mg/L; upper limit of normal, 1 mg/L); other blood tests were within normal limits. Extensive additional diagnostic workup—including serologic testing for anti-aquaporin-4 antibody, anti-DNA antibody, lupus anticoagulant, antinuclear antibody, anti-cardiolipin antibody, and rheumatoid factor—yielded negative results. Lumbar puncture revealed a normal cerebrospinal fluid opening pressure (18 cm H 2 O; upper limit of normal, 25 cm H 2 O). The cerebrospinal fluid was clear, with a normal total nucleated cell count (3.75/mm 3 ; reference range, 0–5/mm 3 ), normal glucose level (53 mg/dL [2.9 mmol/L]; reference range, 50–77 mg/dL [2.8–4.3 mmol/L]), and elevated total protein level (750 mg/L; reference range, 100–450 mg/L). Cerebrospinal fluid oligoclonal bands were positive.